140 related articles for article (PubMed ID: 2145455)
1. [A study of clinical significance of Lp[a] lipoprotein in patients with chronic renal failure treated by hemodialysis].
Takegoshi T; Kitoh C; Yamazaki Y
Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):667-71. PubMed ID: 2145455
[TBL] [Abstract][Full Text] [Related]
2. [Lipoprotein Lp(a) in patients with chronic renal insufficiency on hemodialysis].
Cuxart M; Sans R; Vicente M; Pérez Gallofré A; Masdeu Jufré S; Ponsatí C
Med Clin (Barc); 1989 May; 92(20):769-71. PubMed ID: 2529402
[TBL] [Abstract][Full Text] [Related]
3. [Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis].
Takegoshi T; Kitoh C; Shimada T; Kawai K; Yamazaki Y; Mabuchi H
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):757-63. PubMed ID: 8377289
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
[TBL] [Abstract][Full Text] [Related]
5. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
6. Increased concentrations of Apo B-containing triglyceride-rich lipoprotein particles in patients with chronic renal failure.
Attman PO; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P
Miner Electrolyte Metab; 1992; 18(2-5):199-202. PubMed ID: 1465058
[TBL] [Abstract][Full Text] [Related]
7. Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients.
Güz G; Nurhan Ozdemir F; Sezer S; Işiklar I; Arat Z; Turan M; Haberal M
Am J Kidney Dis; 2000 Oct; 36(4):826-36. PubMed ID: 11007687
[TBL] [Abstract][Full Text] [Related]
8. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
[TBL] [Abstract][Full Text] [Related]
9. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients.
Joy MS; Dornbrook-Lavender KA; Chin H; Hogan SL; Denu-Ciocca C
Ann Pharmacother; 2008 Jan; 42(1):9-15. PubMed ID: 18000162
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein (a) levels and clinical correlations in CAPD patients.
Lye WC; Hughes K; Leong SO; Lee EJ
Adv Perit Dial; 1995; 11():131-3. PubMed ID: 8534686
[TBL] [Abstract][Full Text] [Related]
11. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
12. [Hyperlipidemia in uremic patients in dialysis].
Docci D; Bilancioni R; Turci F; Baldrati L
Quad Sclavo Diagn; 1985 Dec; 21(4):424-9. PubMed ID: 3837917
[TBL] [Abstract][Full Text] [Related]
13. [Alterations of serum lipoprotein (a) levels in continuous ambulatory peritoneal dialysis (CAPD) patients].
Tanaka S
Nihon Jinzo Gakkai Shi; 1994 Jun; 36(6):746-51. PubMed ID: 8084076
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P
J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847
[TBL] [Abstract][Full Text] [Related]
15. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J
Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436
[TBL] [Abstract][Full Text] [Related]
16. Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients.
Yang WS; Kim SB; Min WK; Park S; Lee MS; Park JS
Nephrol Dial Transplant; 1995; 10(9):1668-71. PubMed ID: 8559487
[TBL] [Abstract][Full Text] [Related]
17. [Lipoprotein (a) is a risk factor for cerebrovascular accident in patients with chronic renal failure].
Ishikawa H
Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):846-52. PubMed ID: 8072223
[TBL] [Abstract][Full Text] [Related]
18. Lp(a) levels: effects of progressive chronic renal failure and dietary manipulation.
Monzani G; Bergesio F; Ciuti R; Ciciani AM; Martinelli F; Rosati A; Salvadori M
J Nephrol; 1997; 10(1):41-5. PubMed ID: 9241624
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
Querfeld U; Lang M; Friedrich JB; Kohl B; Fiehn W; Schärer K
Pediatr Res; 1993 Dec; 34(6):772-6. PubMed ID: 8108191
[TBL] [Abstract][Full Text] [Related]
20. [Lipoprotein (a) in children with chronic renal failure treated conservatively].
Zwolińska D; Kiliś-Pstrusińska K; Szprynger K
Pol Merkur Lekarski; 1997 Sep; 3(15):126-8. PubMed ID: 9461709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
